Trials / Unknown
UnknownNCT03622476
Pharmacokinetic (PK)Research on Chinese Children of Hemophilia
Capital Characteristic Application: Pharmacokinetic（PK） Research on Chinese Children of Hemophilia
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 155 (estimated)
- Sponsor
- Beijing Children's Hospital · Academic / Other
- Sex
- Male
- Age
- 1 Year – 14 Years
- Healthy volunteers
- Not accepted
Summary
The study start on June 30, 2018. The Severe(F Ⅷ\<1%) hemophilia A children without F Ⅷ inhibitor combining were recruited to Test the concentration of the drug in the blood to provide better treatment.
Detailed description
Through the integration of two technologies, pharmacokinetics and comprehensive evaluation system, we can improve the individualized prevention and treatment of hemophilia in Chinese children and achieve precise customization of treatment plans. Rational use of medical resources, but also fully achieve the prevention and treatment goals.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | concentrated FVIII | Intervention if the assessment considers that the treatment is inadequate |
Timeline
- Start date
- 2018-06-30
- Primary completion
- 2021-07-30
- Completion
- 2021-08-30
- First posted
- 2018-08-09
- Last updated
- 2018-08-14
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03622476. Inclusion in this directory is not an endorsement.